Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$714,879
+$28,393 QoQ
Shares Held
558,500
+21.2% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,774,319 across 417 Biotechnology names. GERN ranks #155 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $714,879 | 558,500 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $686,486 | 460,729 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,128,785 | 855,141 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,053,882 | 769,258 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $820,537 | 581,942 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,530,808 | 962,773 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,390,143 | 392,696 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,457,335 | 320,999 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,227,029 | 289,394 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $690,930 | 209,373 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $379,391 | 179,807 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,021,975 | 482,065 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,478,389 | 460,558 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $900,540 | 414,996 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $57,293 | 23,675 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,527 | 13,474 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,815 | 22,463 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $64,335 | 47,306 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $185,760 | 152,264 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,114 | 13,953 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,339 | 13,717 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $80,194 | 50,756 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $917,568 | 577,088 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $230,639 | 132,552 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $320,015 | 146,796 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $162,796 | 136,804 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||